Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 371

Similar articles for PubMed (Select 16970598)

1.

Predictive value of serum globulin levels for the extent of hepatic fibrosis in patients with chronic hepatitis B infection.

Schmilovitz-Weiss H, Tovar A, Halpern M, Sulkes J, Braun M, Rotman Y, Tur-Kaspa R, Ben-Ari Z.

J Viral Hepat. 2006 Oct;13(10):671-7.

PMID:
16970598
2.

Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection.

Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, Minuk GY.

J Viral Hepat. 2004 May;11(3):251-6.

PMID:
15117327
3.

Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection.

Schmilovitz-Weiss H, Cohen M, Pappo O, Sulkes J, Braun M, Tur-Kaspa R, Ben-Ari Z.

Clin Transplant. 2007 May-Jun;21(3):391-7.

PMID:
17488390
4.

Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.

Liu XD, Wu JL, Liang J, Zhang T, Sheng QS.

World J Gastroenterol. 2012 Jun 14;18(22):2784-92. doi: 10.3748/wjg.v18.i22.2784.

5.

Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.

Gut. 2008 Apr;57(4):500-6. Epub 2007 Nov 19.

PMID:
18025069
6.

[A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].

Tu XL, Xiao YQ, Chen F.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jan;17(1):28-32. Chinese.

PMID:
19203448
7.
8.

[Relationship between serum HBV DNA levels and hepatic fibrosis markers in chronic hepatitis B].

Dong Z, Shen H, Zhang FK.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007 Jun;21(2):129-31. Chinese.

PMID:
17653313
9.

[Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis].

Park SY, Kang KH, Park JH, Lee JH, Cho CM, Tak WY, Kweon YO, Kim SK, Choi YH.

Korean J Gastroenterol. 2004 Apr;43(4):246-51. Korean.

10.

[Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].

Kozłowska J, Łoch T, Jabłońska J, Cianciara J.

Przegl Epidemiol. 2001;55(4):451-8. Polish.

PMID:
11921731
11.

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease.

Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, Forouzanfar MH, Abedian S, Tavangar SM, Mohamadkhani A, Ghoujeghi F, Estakhri A, Nouri N, Farzadi Z, Najjari A, Malekzadeh R.

Am J Gastroenterol. 2006 Nov;101(11):2537-45. Epub 2006 Oct 4.

PMID:
17029616
12.

Efficacy of interferon therapy on serum fibronectin levels in children with chronic hepatitis B infection.

Helvaci M, Ozkaya B, Ozbal E, Ozinel S, Yaprak I.

Pediatr Int. 1999 Jun;41(3):270-3.

PMID:
10365576
13.

Decline of serum HBV DNA and no change apportioned by the same hepatic parenchyma cell volume from hepatic fibrosis stage 1 to stage 4 during the natural history of chronic hepatitis B.

Ke WM, Xie SB, Yu LN, Liu T, Lai J, He DQ, Li XH, Gao ZL, Ke Y, Chen PJ.

Intervirology. 2008;51(4):235-40. doi: 10.1159/000156482. Epub 2008 Sep 24.

PMID:
18812696
14.

Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B.

Shin WG, Park SH, Jang MK, Hahn TH, Kim JB, Lee MS, Kim DJ, Jun SY, Park CK.

Dig Liver Dis. 2008 Apr;40(4):267-74. Epub 2007 Dec 4.

PMID:
18055281
15.

Clinical, virological, and pathological significance of hepatic bile duct injuries in Chinese patients with chronic hepatitis C.

Hwang SJ, Luo JC, Chu CW, Lai CR, Tsay SH, Chang FY, Lee SD.

J Gastroenterol. 2001 Jun;36(6):392-8.

PMID:
11428585
16.

[Serum globulin levels and intensity of hepatic fibrosis in patients with mansonic schistosomiasis].

Correia HS, Domingues AL, Lopes EP, Morais CN, Sarteschi C, Moura IM.

Arq Gastroenterol. 2009 Jul-Sep;46(3):194-8. Portuguese.

17.

Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.

Dai CY, Chuang WL, Hou NJ, Lee LP, Hsieh MY, Lin ZY, Chen SC, Huang JF, Hsieh MY, Wang LY, Tsai JF, Wen-Yu, Yu ML.

Clin Ther. 2006 Dec;28(12):2081-92.

PMID:
17296464
18.

Altered serum N-glycomics in chronic hepatitis B patients.

Gui HL, Gao CF, Wang H, Liu XE, Xie Q, Dewaele S, Wang L, Zhuang H, Contreras R, Libert C, Chen C.

Liver Int. 2010 Feb;30(2):259-67. doi: 10.1111/j.1478-3231.2009.02170.x. Epub 2009 Nov 27.

PMID:
19951379
19.

Insulin resistance is not associated with histologic severity in nondiabetic, noncirrhotic patients with chronic hepatitis B virus infection.

Park SH, Kim DJ, Lee HY.

Am J Gastroenterol. 2009 May;104(5):1135-9. doi: 10.1038/ajg.2009.6. Epub 2009 Mar 24.

PMID:
19319126
20.

The level of connective tissue growth factor in sera of patients with hepatitis B virus strongly correlates with stage of hepatic fibrosis.

Guo-Qiu W, Nai-Feng L, Xiao-Bo V, Linxian L, Chen Z, Lixia G, Zhao L.

Viral Immunol. 2010 Feb;23(1):71-8. doi: 10.1089/vim.2009.0067.

PMID:
20121404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk